Member
The Centers for Medicare & Medicaid Services’ Hospital Price Transparency final rule goes into effect on Jan. 1, 2021. The AHA and three other national organizations sued the federal government challenging the final rule. The case is pending in a federal appeals court.
The Centers for Medicare & Medicaid Services (CMS) May 20 issued a proposed rule that would implement certain statutory changes under Section 71116 of Public Law No. 119-21, the reconciliation bill passed in July 2025.
In this member webinar, Jonathan Gold, Senior Associate Director, Post-Acute Payment Policy and Caitlin Gillooley, Director, Quality & Behavioral Health Policy, presents an overview of the FY 2027 Proposed Rules for IRF, SNF, LTCH. They summarize the principal policy changes proposed and…
H-ISAC TLP Green: Daily Cyber Headlines for May 21, 2026..
A daily ransomware tracker at TLP Green to increase awareness of the ransomware threat.
REMINDER: AHA seeks hospital input on scope of drug company 340B data policy compliance by May 26 deadline.
Hospitals and health systems have always been at the forefront of medical science, often leading in the development of new drugs, devices, digital tools and care delivery models that make care safer, more efficient and more effective.
Hospitals and health systems are working to make prescription drugs more affordable by carefully managing formularies, using biosimilars and generics where appropriate, and leveraging programs like the 340B Drug Pricing Program to stretch scarce resources for vulnerable patients.
The U.S. health care system operates with extensive compliance, reporting and documentation requirements. There is a substantial opportunity to streamline these through standardization.
Transforming how care is delivered is essential to ensuring that America’s health care system overall is high quality and affordable.